Gach J E, Ilchyshyn A
Department of Dermatology, Walsgrave Hospital, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Clin Exp Dermatol. 2004 May;29(3):271-2. doi: 10.1111/j.1365-2230.2004.01499.x.
We report a case of pemphigus vulgaris in which a recalcitrant area of erosion on the cheek cleared only when topical tacrolimus was used in addition to a regime of systemic therapy consisting of cyclophosphamide and prednisolone. Clinical improvement occurred within 10 days of applying topical tacrolimus with healing of erosions and reduction in pain and burning sensations. Topical tacrolimus may inhibit local activation of T lymphocytes through altered expression of cytokines such as interleukin-1, -4 and -5, tumour necrosis factor-alpha and interferon-gamma. Some of these cytokines may also contribute directly to increasing keratinocyte fragility in the aetiology of pemphigus vulgaris erosions. This case illustrates that topical tacrolimus may be a useful adjunct in the management of patients with pemphigus vulgaris.
我们报告了一例寻常型天疱疮病例,患者脸颊上有一处顽固的糜烂区域,在使用环磷酰胺和泼尼松龙进行全身治疗的同时加用局部他克莫司后才得以清除。在应用局部他克莫司10天内出现临床改善,糜烂愈合,疼痛和烧灼感减轻。局部他克莫司可能通过改变白细胞介素-1、-4和-5、肿瘤坏死因子-α和干扰素-γ等细胞因子的表达来抑制T淋巴细胞的局部活化。其中一些细胞因子也可能在寻常型天疱疮糜烂的病因中直接导致角质形成细胞脆性增加。该病例表明局部他克莫司可能是寻常型天疱疮患者管理中的一种有用辅助药物。